Pasuruan, East Java (ANTARA) - The National Agency of Drug and Food\nControl (BPOM) supports the strengthening of the local pharmaceutical\nindustry to reduce dependence on imported drug raw materials, which\nreaches 80 per cent, and to increase the domestic pharmaceutical\nsector\u2019s production capacity.<\/p>\n
\u201cFinished drug products in the country are indeed dominated by local\nones, but raw materials still rely on imports up to 70-80 per cent; this\nis what we must promote self-reliance in,\u201d said BPOM\u2019s Deputy for Drug,\nNarcotics, Psychotropics, Precursors, and Addictive Substances\nSupervision (Deputy 1) William Adi Teja at the inauguration of Satoria\nPharma\u2019s Line 4 Factory in Pasuruan, East Java, on Tuesday.<\/p>\n
According to him, dependence on imported raw materials remains a\nchallenge for the national pharmaceutical industry, even though 80 per\ncent of domestic drug needs are met by local producers.<\/p>\n
This, he said, is one of the factors slowing the strengthening of the\nnational chemical and pharmaceutical sector.<\/p>\n
He explained that one potential to be developed is the domestic\npharmaceutical salt industry, which is an important raw material for\ninfusion fluid production.<\/p>\n
He mentioned that Indonesia currently has four pharmaceutical salt\nindustry companies, three of which are located in East Java, capable of\nproducing up to 4,000 tonnes per year.<\/p>\n
In addition, he stated that expanding infusion fluid production\ncapacity by the pharmaceutical industry, such as done by PT Satoria\nAneka Industri through its Satoria Pharma business unit, which is a\ndomestic infusion producer, is expected to strengthen national\npharmaceutical resilience while ensuring the availability of safe,\nquality, and effective products.<\/p>\n
\u201cWith increased production capacity and the addition of new lines, we\nhope the national pharmaceutical industry becomes increasingly\nindependent,\u201d he said.<\/p>\n
Meanwhile, CEO and Founder of PT Satoria Aneka Industri Alim Satria\nstated that with the inauguration of the Satoria Pharma Line 4 factory,\nthe company is targeted to produce up to 230 million infusion bottles\nper year.<\/p>\n
The company is also preparing to build Line 5 factory, which will\nincrease infusion production capacity to 400 million bottles per year,\nplanned to be realised in 2028.<\/p>\n
He emphasised that the company is ready to continue ensuring product\navailability and improving quality to support the creation of import\nsubstitution industry independence, especially in the domestic\npharmaceutical sector.<\/p>", "url": "https:\/\/jawawa.id\/newsitem\/bpom-pushes-for-strengthening-pharmaceutical-industry-to-reduce-imports-of-raw-materials-1777380712", "image": "" }, "sponsor": "Okusi Associates", "sponsor_url": "https:\/\/okusiassociates.com" }